African Journal of
Medical and Health Sciences

OFFICIAL PUBLICATION OF THE FEDERAL TEACHING HOSPITAL, ABAKALIKI, NIGERIA
  • Abbreviation: Afr. J. Med. Health Sci.
  • Language: English
  • ISSN: 2384-5589
  • DOI: 10.5897/AJMHS
  • Start Year: 2017
  • Published Articles: 20

Full Length Research Paper

Sero-prevalence of Hepatitis B and C infection among patients with end stage renal disease at haemodialysis initiation

Ogochukwu Chinedum Okoye
  • Ogochukwu Chinedum Okoye
  • Department of Medicine, Delta State University, Abraka, Nigeria.
  • Google Scholar


  •  Received: 15 October 2019
  •  Accepted: 15 January 2020
  •  Published: 29 February 2020

References

Akinsola A, Olusanya O, Iyun AO, Mbanefo CO (1984). Role of hepatitis Bs antigen in chronic glomerulonephritides in Nigerians. Africa Journal of Medicine and Medical Science 13:33‑39.

 

Alashek WA, McIntyre CW, Taal MW (2012). Hepatitis B and C infection in haemodialysis patients in Libya: prevalence, incidence and risk factors. BMC Infect Disease 12:265.
Crossref

 

Amira CO, Lesi OA (2017). Seroprevalence of hepatitis B and C infection among Nigerian subjects with chronic kidney disease. Journal Clinical Science 14:58-61.
Crossref

 

Assarehzadegan MA, Shakerinejad G, Noroozkohnejad R, Amini A, Rahim Rezaee SA (2009). Prevalence of hepatitis C and B infection and HCV genotypes among hemodialysis patients in Khuzestan province, southwest Iran. Saudi Journal of Kidney Disease and Transplanting 20:681-684.

 

Ayodele OE, Salako BL, Kadiri S, Arije A, Alebiosu CO (2006). Hepatitis B virus infection: Implications in chronic kidney disease, dialysis and transplantation. Africa Journal of Medicine Medical Science 35:111‑119.

 

Bahri F, Kheirabad AK, Ghasemzadeh I, Shoja S, Gouklani H (2016). Hepatitis Viruses B and D and Human Immunodeficiency Virus Infections in Hemodialysis Patients in the South of Iran: Prevalence and Genotypes. Hepatology Mon. 16(1):e32971
Crossref

 

Bernieh B (2015). Viral hepatitis in hemodialysis: an update. Journal of Translational Internal Medicine 3(3):93-105.
Crossref

 

Bhimma R, Coovadia HM, Adhilari M (1998). Hepatitis B virus‑associated nephropathy membranous nephropathy in black South African children. Pediatrician Nephrology 11:429‑34.

 

Burdick RA, Bragg-Gresham JL, Woods JD, Hedderwick SA, Kurokawa K, Combe C, Saito A, LaBrecque J, Port FK, Young EW (2003). Patterns of hepatitis B prevalence and seroconversion in hemodialysis units from three continents: the DOPPS. Kidney International 63(6):2222-2229.
Crossref

 

Daw MA, Elkaber MA, Drah AM, Werfalli MM, Mihat AA, Siala IM (2002). Prevalence of hepatitis C virus antibodies among different populations of relative and attributable risk. Saudi Medical Journal 23(11):1356-1360.

 

Edey M, Barraclough K, Johnson DW (2010). Review article: Hepatitis B and dialysis. Nephrology (Carlton) 15:137-45.
Crossref

 

Fabrizi F, Poordad F, Martin P (2002). Hepatitis C. Infection and the patients with end-stage renal disease. Hepatology 36(1):3-10.
Crossref

 

Fabrizi F, Verdesca S, Messa P, Martin P (2015). Hepatitis C virus infection increases the risk of developing chronic kidney disease: a systematic review and meta-analysis. Dig Disease Science 60(12):3801-3813.
Crossref

 

Fabrizi F (2013). Hepatitis C virus infection and dialysis: 2012 update. ISRN nephrology 159760.
Crossref

 

Garima M, Gupta P, Thakuriaz B, Mukhiyax GK, Mittaly M (2013). Profile of Hepatitis B Virus, Hepatitis C Virus, Hepatitis D Virus and Human Immunodeficiency Virus Infections in Hemodialysis Patients of a Tertiary Care Hospital in Uttarakhand. Journal Clinical Experimental Hepatology 3:24-28
Crossref

 

Halle MP, Choukem SP, Kaze FF, Ashuntantang G, Tchamago V (2016). Hepatitis B, Hepatitis C and Human immune deficiency virus seroconversion positivity rates and their potential risk factors among patients on maintenance hemodialysis in Cameroon. Iranian Journal of Kidney Diseases 10(5):304-309.

 

Jadoul M, Martin P (2017). Hepatitis C Treatment in Chronic Kidney Disease Patients: The Kidney Disease Improving Global Outcomes Perspective. Blood Purification 43:206-209.
Crossref

 

Jibrin B, Jiya NM, Ahmed H (2014). Seroprevalence of hepatitis C virus antibody and its associated risk factors in children with sickle cell anaemia. Sub-Saharan Africa Journal of Medicine 1:20-25.
Crossref

 

Lesi OA, Kehinde MO (2003). Hepatitis C virus infection in patients with sickle cell anaemia at the Lagos University Hospital. Niger Postgraduate Medical Journal 10:79‑83.

 

Luma HN, Halle MP, Eloumou SAF, Azingala F, Kamdem F, Donfack-Sontsa O, Ashuntantang G (2017). Seroprevalence of human immunodeficiency virus, hepatitis B and C viruses among haemodialysis patients in two newly opened centres in Cameroon. 
Crossref

 

Musa B, Bussell S, Borodo MM, Samaila AA, Femi OL (2015). Prevalence of hepatitis B virus infection in Nigeria, 2000-2013: A systematic review and meta-analysis. Niger Journal Clinical Practice 18:163-167.
Crossref

 

Rinonce HT, Yano Y, Utsumi T, Heriyanto DS, Anggorowati N, Widasari DI (2013). Hepatitis B and C virus infection among hemodialysis patients in Yogyakarta, Indonesia: Prevalence and molecular evidence for nosocomial transmission. Journal of Medicine and Virology 85:1348‑61.
Crossref

 

Suliman AM, Busaobiuah J, Al-Baqshi M, Qadiaub K, Bushrah M, Homrany H, Aljassam A, Khan SA (2013). Prevalence of hepatitis B and C in adult sickle cell disease patients in the eastern province of Saudi Arabia. Journal Applied Hematology 4:33-35

 

Ulasi II, Ijoma CK (2010). The enormity of chronic kidney disease in Nigeria: the situation in a teaching hospital in south-east Nigeria. Journal of Tropical Medicine pp. 1-6.
Crossref

 

World Health Organization (2017). Hepatitis Global hepatitis report, 

View